|
WO2017180764A1
|
|
Focused interferon immunotherapy
|
|
WO2017091611A1
|
|
Enhanced cancer immunotherapy using antibody-interferon fusion molecules
|
|
WO2017087843A1
|
|
Methods of treating proliferative diseases using engineered antibody-interferon fusion molecules
|
|
US2018312561A1
|
|
Focused interferon immunotherapy for treatment of cancer
|
|
WO2016201350A1
|
|
Combination therapy for treatment of cancer
|
|
WO2016201337A1
|
|
Engineered antibody-interferon fusion molecules for the treatment of glucose-regulated protein 94 (grp94) expressing cancers
|
|
WO2014028502A1
|
|
Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases
|
|
US2013230517A1
|
|
Engineered antibody-interferon mutant fusion molecules
|
|
WO2012170072A1
|
|
Engineered antibody-tnfsf member ligand fusion molecules
|
|
AU2009223784A1
|
|
Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
|
